文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脂联素、瘦素与血脂谱刻画ICU患者代谢高危表型

Adiponectin, Leptin, and Lipid Profiles Characterize a Metabolic High-Risk Phenotype in ICU Patients.
PubMed 文献 · Shock · 2026-02-05
一句话结论ICU入院时高脂联素、低总胆固醇组合定义HALC高危表型,30天累积生存率低于20%,风险比12.888。

本研究为前瞻性单中心研究,纳入224例连续ICU患者,入院时检测脂联素、瘦素及标准血脂参数。结果发现非存活者脂联素显著升高、总胆固醇显著降低(均P<0.001),两者均独立预测30天死亡率(P<0.001)。高脂联素低胆固醇(HALC)表型患者30天累积生存率低于20%,与低危表型相比风险比12.888(P<0.001),该关联独立于年龄、性别、肌酐和体重指数。将脂联素和胆固醇加入SAPS II评分可提高预测准确性(AUC 0.85 vs 0.81,P=0.039)。

要点

  • ICU入院时高脂联素、低总胆固醇(HALC表型)患者30天累积生存率低于20%,与低危表型相比HR 12.888(P<0.001)。
  • 非存活者脂联素显著升高、总胆固醇显著降低(均P<0.001),两者均独立预测30天死亡率(P<0.001)。
  • HALC表型与30天死亡风险的关联独立于年龄、性别、肌酐和体重指数。
  • 脂联素和总胆固醇联合SAPS II评分使AUC从0.81提高到0.85(P=0.039)。
  • 瘦素和甘油三酯在整体队列中无预后关联,但在HALC组内均显著降低。

适用人群与场景

  • 前瞻性单中心研究纳入的224例连续ICU患者,入院时采集血样检测脂联素、瘦素及标准血脂参数。

诊断标准与关键阈值

  • HALC高危表型定义为高脂联素、低总胆固醇;原文未给出脂联素和总胆固醇的具体界值。

研究设计与关键结果

  • 前瞻性单中心研究,224例连续ICU患者,入院时检测脂联素、瘦素、总胆固醇和甘油三酯,主要终点为30天死亡率。
  • 非存活者脂联素水平显著升高,总胆固醇显著降低(均P<0.001);两者均独立预测30天死亡率(P<0.001)。
  • HALC表型(高脂联素、低胆固醇)患者30天累积生存率低于20%,与低危表型相比HR 12.888(P<0.001),独立于年龄、性别、肌酐和体重指数。
  • 瘦素和甘油三酯在整体队列中无预后关联,但在HALC组内均显著降低。
  • 脂联素和胆固醇联合SAPS II评分使AUC从0.81提高到0.85(P=0.039)。

证据类型、等级与局限

  • 证据类型:前瞻性单中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,HALC表型可能通过捕捉常规评分系统未覆盖的代谢失调来改善ICU结局预测。
  • 作者认为,脂联素和总胆固醇似乎是生存的强预测因子,并可能反映危重病的互补方面。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Critical illness triggers profound metabolic and inflammatory changes, yet interactions between adipokines and lipid metabolism remain poorly understood. This study examined the prognostic value of adiponectin, leptin, their ratio, and standard lipid parameters at intensive care unit (ICU) admission and explored their combined association with 30-day mortality.

METHODS: In this prospective, single-center study, 224 consecutive ICU patients were enrolled. Adiponectin and leptin were quantified by enzyme-linked immunosorbent assay, and standard lipid parameters, including total cholesterol and triglycerides, were measured at admission in the central laboratory.

RESULTS: Adiponectin levels were markedly elevated in nonsurvivors, whereas total cholesterol was significantly reduced (both P < 0.001). Both markers independently predicted 30-day mortality ( P < 0.001). Their combination defined a distinct high-risk phenotype (HALC: high adiponectin, low cholesterol) with a cumulative survival rate below 20%. Compared with patients exhibiting a low-risk phenotype, those in the HALC group had a hazard ratio of 12.888 ( P < 0.001). This finding was independent of age, sex, creatinine, and body mass index. While leptin and triglycerides showed no prognostic association in the overall cohort, both were significantly lower within the HALC group. Integrating adiponectin and cholesterol with the Simplified Acute Physiology Score II score further improved its predictive accuracy (area under the curve 0.85 vs. 0.81, P = 0.039).

CONCLUSIONS: Adiponectin and total cholesterol are strong predictors of survival and appear to capture complementary aspects of critical illness. Their combination defines a high-risk phenotype with markedly reduced 30-day survival. The HALC profile may improve ICU outcome prediction by capturing metabolic dysregulation not captured by conventional scoring systems.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Steinacher E, Bernhard J, Zilberszac R, et al. Adiponectin, Leptin, and Lipid Profiles Characterize a Metabolic High-Risk Phenotype in ICU Patients. Shock. 2026. PMID: 41735188. doi:10.1097/SHK.0000000000002814

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。